This article was originally published in The Gray Sheet
Will preview Acoustic Response Technology, a new option for its 128XP/10 ultrasound system, at technology seminars beginning in May in 15 cities worldwide. In an April 7 press release, the firm says it expects ART to improve image quality in "a broad range of clinical applications, including abdominal, obstetrical, vascular and small parts (for example, breasts and testicles)".
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.